[CYCC] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
10-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 6.13%
YoY- -19.08%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 29 31 16 373 0 0 0 -
PBT -7,225 -6,093 -6,699 -6,034 -7,124 -9,000 -6,110 11.81%
Tax -4,279 -822 -602 -586 -1,320 -1,581 -1,014 160.90%
NP -2,946 -5,271 -6,097 -5,448 -5,804 -7,419 -5,096 -30.58%
Tax Rate - - - - - - - -
Total Cost 2,975 5,302 6,113 5,821 5,804 7,419 5,096 -30.12%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -10,158.62 -17,003.23 -38,106.25 -1,460.59 0.00 0.00 0.00 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -2.27 -6.17 -7.23 -6.51 -6.94 -8.87 -0.41 212.63%
EPS Diluted -2.27 -6.17 -7.23 -6.51 -6.94 -8.87 -0.41 212.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.